Here is another stroll down the CV-19 memory lane. You may recall that during the epidemic Dave Dixon and I made multiple efforts to get the state to release data on CV-19 hospitalizations that were either incidental–the admission wasn’t for CV-19, or the infection was actually acquired in the hospital. The state refused to provide any information, notwithstanding the fact that it had the data; and it kept insisting that any such hospitalizations were very rare. That was garbage, as some federal data showed high levels of incident hospitalizations. The study looked at almost 300 hospitals with over 170,000 CV-19 hospitalizations. In at least 4.4% of the hospitalizations CV-19 was acquired in the hospital, and in another 3.8% it could have been. Various studies have shown the incidental hospitalization rate to be much higher. The importance of this is that hospitalizations were constantly used as a key metric in the terror campaign and including hospitalizations that were incidental or actually acquired in a hospital makes that number misleading high. (JAMA Study)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace